News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanotherapeutics Receives U.S. Department of Defense Contract for Clinical Trial to Treat Dehisced Wounds with NanoDOX(R) Hydrogel


11/3/2010 10:01:22 AM

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc. announced that it has been awarded a contract by the U.S. Department of Defense (DOD) to support a clinical trial for treating dehisced surgical wounds with the Company’s NanoDOX® Hydrogel, a topical doxycycline hydrogel for chronic wounds. Nanotherapeutics is collaborating with Walter Reed Army Medical Center, the Henry Jackson Foundation, and the Armed Forces Institute of Pathology to conduct the trial. Funds were made available from the DOD 2009 Congressional appropriation for the Accelerating Treatment for Trauma Wounds.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES